Tradestie Institutional Equity Comparison Engine

SANA vs ZVRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ZVRA Overall Edge

ZVRA Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Zevra Therapeutics, Inc. Common Stock (ZVRA) driven by superior Valuation, Growth & Margin, Momentum & Technical while SANA counters with relative strength in Options & Structure. Fundamentally, SANA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ZVRA at 10.4x Forward P/E and 31.5% operating margin (+44.9% YoY). In options structure, SANA sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against ZVRA sits in BREAKDOWN (18th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ZVRA
SANA N/M vs ZVRA 10.4x Fwd P/E
Growth & Margin Winner ZVRA
Op Margin 0.0% vs 31.5% ยท YoY +0.0% vs +44.9%
Momentum & Technical Winner ZVRA
1Y -48.6% vs +0.2% ยท 52W Pos 1% vs 18%
Options & Structure Winner SANA
BREAKDOWN (4th %ile IV) vs BREAKDOWN (18th %ile IV)
SANA NASDAQ
Sana Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$1.88
-6.93% 1D
Market Cap $605.3M
1M Return -17.18%
1Y Return -48.63%
Forward P/E N/M
Unified AI Score
44.3 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 66.0 Mom 60.0
ZVRA NASDAQ
Zevra Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.25
+1.87% 1D
Market Cap $540.3M
1M Return -6.94%
1Y Return +0.22%
Forward P/E 10.4x
Unified AI Score
49.4 / 100 HOLD
Tech 37.0 Fund 53.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SANA -48.63% ZVRA +0.22% Spread: +48.85 pp (ZVRA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SANA TTM Op. Margin: 0.0% ZVRA TTM Op. Margin: 31.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SANA vs ZVRA. Trailing 12-month operating profitability (SANA 0.0% vs ZVRA 31.5%) and valuation multiples (SANA N/M vs ZVRA 10.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SANA (2) vs ZVRA (8)
Institutional Metric SANA ZVRA Criterion Row Winner
Market Capitalization Scale $605.3M $540.3M Larger Scale SANA
Trailing P/E Ratio Valuation N/M 7.4x Lower Multiple ZVRA
Forward P/E Ratio Valuation N/M 10.4x Lower Multiple ZVRA
Revenue Growth (YoY) Growth +0.0% +44.9% Higher Growth ZVRA
Operating Margin (TTM) Profitability 0.0% 31.5% Higher Margin ZVRA
Net Profit Margin Profitability 0.0% 52.8% Higher Margin ZVRA
Return on Equity (ROE) Capital Efficiency -79.5% 41.9% Higher ROE ZVRA
52-Week Range Position Momentum 1% ($2โ€“$5) 18% ($8โ€“$15) Stronger Trend ZVRA
Beta / 30D Volatility Risk Regime 1.82ฮฒ ยท 78% Vol 1.19ฮฒ ยท 94% Vol Lower Realized Risk SANA
Unified Institutional Score Composite Signal 44.3 / 100 (HOLD) 49.4 / 100 (HOLD) Higher Composite ZVRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SANA vs ZVRA Buy Guide
SANA BREAKDOWN
57d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live SANA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ZVRA BREAKDOWN
111d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 18th %ile
IV Regime Compressed (<25th %ile)
Live ZVRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SANA nor ZVRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.